ArticleEClinicalMedicine2020

Evaluating the evidence behind the surrogate measures included in the FDA's table of surrogate endpoints as supporting approval of cancer drugs.

Bishal Gyawali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.